Trimethoprim causes a marked increase in the
plasma levels of
procainamide and its active
metabolite, N-acetylprocainamide. Note that
co-trimoxazole contains trimetho- prim.
The need to reduce the
procainamide dosage should be anticipated if trimetho- prim is given to patients already controlled on
procainamide.